BIOMAT Database Logo BIOMAT Database Logo

Persistent uptake of indium-111-antimyosin monoclonal antibody in patients with myocardial infarction. 1990

A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.

Indium-111(111In)-antimyosin scintigraphy was investigated in 27 patients with myocardial infarction. 111In-antimyosin Fab was administered intravenously, and planar and single photon emission computed tomographic images were obtained 48 hours later. Uptake of 111In-antimyosin was present in 9 of 10 patients (90%) studied within 6 days of infarction. During the second week positive scans were seen in 16 of 16 patients (100%) including 13 (81%) who had normal creatine kinase levels. The mechanism of persistent positive antimyosin images in the subacute stage of myocardial infarction remains to be clarified. 111In-antimyosin scintigraphy may be useful as a noninvasive method for the detection of myocardial injury late and early after a suspected acute myocardial infarction.

UI MeSH Term Description Entries
D007205 Indium Radioisotopes Unstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes. Radioisotopes, Indium
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009218 Myosins A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain. Myosin ATPase,ATPase, Actin-Activated,ATPase, Actomyosin,ATPase, Myosin,Actin-Activated ATPase,Actomyosin ATPase,Actomyosin Adenosinetriphosphatase,Adenosine Triphosphatase, Myosin,Adenosinetriphosphatase, Actomyosin,Adenosinetriphosphatase, Myosin,Myosin,Myosin Adenosinetriphosphatase,ATPase, Actin Activated,Actin Activated ATPase,Myosin Adenosine Triphosphatase
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
What factors determine indium-111 antimyosin monoclonal antibody uptake in patients with myocardial infarction?
July 1993, International journal of cardiology,
A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Blood flow-dependent uptake of indium-111 monoclonal antimyosin antibody in canine acute myocardial infarction.
January 1993, Journal of the American College of Cardiology,
A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Value of indium-111 monoclonal antimyosin antibody for imaging in acute myocardial infarction.
September 1987, The American journal of cardiology,
A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Indium-111 antimyosin monoclonal antibody Fab imaging in patients with cardiomyopathy.
February 1995, Annals of nuclear medicine,
A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Myocardial indium-111-antimyosin uptake in essential hypertension.
June 2003, Nuklearmedizin. Nuclear medicine,
A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Indium-111-antimyosin uptake in acute and remote myocardial infarction: comparison with pathohistologic findings.
April 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Imaging of acute myocardial infarction in pigs with Indium-111 monoclonal antimyosin scintigraphy and MRI.
July 1990, Investigative radiology,
A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab.
November 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
September 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A Matsumori, and T Yamada, and N Tamaki, and C Kawai, and Y Watanabe, and Y Yonekura, and K Endo, and J Konishi, and A Yoshida, and S Tamaki
Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis.
August 1987, Circulation,
Copied contents to your clipboard!